Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation
Authors
Keywords
-
Journal
TUMOR BIOLOGY
Volume 39, Issue 3, Pages 101042831769100
Publisher
SAGE Publications
Online
2017-03-29
DOI
10.1177/1010428317691001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor vascular infarction: prospects and challenges
- (2017) Rana Jahanban-Esfahlan et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Modulating tumor hypoxia by nanomedicine for effective cancer therapy
- (2017) Rana Jahanban-Esfahlan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The antibody-mediated targeted delivery of interleukin-13 to syngeneic murine tumors mediates a potent anticancer activity
- (2015) Christian Hess et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The role for autophagy in cancer
- (2015) Eileen White JOURNAL OF CLINICAL INVESTIGATION
- Anti-Endosialin Antibody-Drug Conjugate: Potential in Sarcoma and Other Malignancies
- (2015) C. Rouleau et al. MOLECULAR CANCER THERAPEUTICS
- Broad targeting of angiogenesis for cancer prevention and therapy
- (2015) Zongwei Wang et al. SEMINARS IN CANCER BIOLOGY
- Nab-paclitaxel Efficacy in the Orthotopic Model of Human Breast Cancer Is Significantly Enhanced By Concurrent Anti–Vascular Endothelial Growth Factor A Therapy
- (2015) Lisa D. Volk et al. NEOPLASIA
- Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
- (2014) Naveen S. Vasudev et al. ANGIOGENESIS
- Antibody-Based Delivery of IL2 and Cytotoxics Eradicates Tumors in Immunocompetent Mice
- (2014) K. L. Gutbrodt et al. MOLECULAR CANCER THERAPEUTICS
- Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales
- (2013) Asmaa E El-Kenawi et al. BRITISH JOURNAL OF PHARMACOLOGY
- The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer
- (2013) Teresa Hemmerle et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor Delivery of Chemotherapy Combined with Inhibitors of Angiogenesis and Vascular Targeting Agents
- (2013) Marta Cesca et al. Frontiers in Oncology
- The Antibody-Based Delivery of Interleukin-12 to the Tumor Neovasculature Eradicates Murine Models of Cancer in Combination with Paclitaxel
- (2012) N. Pasche et al. CLINICAL CANCER RESEARCH
- Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors
- (2012) Yan Xia et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The Immunocytokine L19–IL2 Eradicates Cancer When Used in Combination with CTLA-4 Blockade or with L19-TNF
- (2012) Kathrin Schwager et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Circulating Endothelial Progenitors and Tumor Resistance to Vascular-Targeting Therapies
- (2012) Michele De Palma et al. Cancer Discovery
- The targeted delivery of IL17 to the mouse tumor neo-vasculature enhances angiogenesis but does not reduce tumor growth rate
- (2011) Nadine Pasche et al. ANGIOGENESIS
- A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels
- (2011) A Palumbo et al. BRITISH JOURNAL OF CANCER
- Inhibition of Tumor Angiogenesis by Antibodies, Synthetic Small Molecules and Natural Products
- (2011) O. Wahl et al. CURRENT MEDICINAL CHEMISTRY
- Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy
- (2011) R Gardlik et al. GENE THERAPY
- Anti-angiogenesis immunotherapy
- (2011) Jonathan D. Schoenfeld et al. Human vaccines & immunotherapeutics
- Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation
- (2011) Katharina Frey et al. Integrative Biology
- Cloning and characterization of novel tumor-targeting immunocytokines based on murine IL7
- (2011) Nadine Pasche et al. JOURNAL OF BIOTECHNOLOGY
- TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice
- (2011) Abigail F. Welford et al. JOURNAL OF CLINICAL INVESTIGATION
- Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts
- (2011) Shousong Cao et al. ORAL ONCOLOGY
- Combination of temozolomide with immunocytokine F16–IL2 for the treatment of glioblastoma
- (2010) M Pedretti et al. BRITISH JOURNAL OF CANCER
- Hypoxia inducible factors in cancer stem cells
- (2010) J M Heddleston et al. BRITISH JOURNAL OF CANCER
- Molecular mechanisms underlying tumor dormancy
- (2010) Nava Almog CANCER LETTERS
- Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy
- (2010) Amir Abdollahi et al. DRUG RESISTANCE UPDATES
- Mechanisms of resistance to antiangiogenesis therapy
- (2010) Faisal Azam et al. EUROPEAN JOURNAL OF CANCER
- The Immunocytokine F8-IL2 Improves the Therapeutic Performance of Sunitinib in a Mouse Model of Renal Cell Carcinoma
- (2010) Katharina Frey et al. JOURNAL OF UROLOGY
- Radiolabeled Cyclic RGD Peptides as Integrin αvβ3-Targeted Radiotracers: Maximizing Binding Affinity via Bivalency
- (2009) Shuang Liu BIOCONJUGATE CHEMISTRY
- Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience
- (2009) R. Bieker et al. BLOOD
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Hypoxia-inducible factor in cancer angiogenesis: Structure, regulation and clinical perspectives
- (2009) Zaher K. Otrock et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Vascular Disrupting Agents: A Novel Mechanism of Action in the Battle Against Non-Small Cell Lung Cancer
- (2009) C. Gridelli et al. ONCOLOGIST
- Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2
- (2008) C. Schliemann et al. BLOOD
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
- (2008) Rose Du et al. CANCER CELL
- The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
- (2008) Takuya Osada et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven
- (2008) Ruud P.M. Dings et al. CANCER LETTERS
- Containment of Tumor-Colonizing Bacteria by Host Neutrophils
- (2008) K. Westphal et al. CANCER RESEARCH
- Dopamine Increases the Efficacy of Anticancer Drugs in Breast and Colon Cancer Preclinical Models
- (2008) C. Sarkar et al. CLINICAL CANCER RESEARCH
- A fusion protein containing murine vascular endothelial growth factor and tissue factor induces thrombogenesis and suppression of tumor growth in a colon carcinoma model
- (2008) Feng-ying Huang et al. Journal of Zhejiang University-SCIENCE B
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now